Cyclic nitric oxide release by human granulocytes, and invertebrate ganglia and immunocytes: nano-technological enhancement of amperometric nitric oxide determination.
暂无分享,去创建一个
[1] S. Bouret,et al. Median eminence nitric oxide signaling , 2000, Brain Research Reviews.
[2] G. Stefano,et al. Rebound from Nitric Oxide Inhibition Triggers Enhanced Monocyte Activation and Chemotaxis1 , 2000, The Journal of Immunology.
[3] T. Bilfinger,et al. Antagonism of LPS and IFN-gamma induced iNOS expression in human atrial endothelia by morphine, anandamide, and estrogen. , 2000, Acta pharmacologica Sinica.
[4] T. Bilfinger,et al. Basal nitric oxide limits immune, nervous and cardiovascular excitation: human endothelia express a mu opiate receptor , 2000, Progress in Neurobiology.
[5] Xueji Zhang,et al. Novel Calibration Method for Nitric Oxide Microsensors by Stoichiometrical Generation of Nitric Oxide from SNAP , 2000 .
[6] M. Shichiri,et al. NO Inhibits Cytokine-Induced iNOS Expression and NF-κB Activation by Interfering With Phosphorylation and Degradation of IκB-α , 1998 .
[7] T. Bilfinger,et al. Antagonism of LPS and IFN-gamma induction of iNOS in human saphenous vein endothelium by morphine and anandamide by nitric oxide inhibition of adenylate cyclase. , 1998, Journal of cardiovascular pharmacology.
[8] T. Bilfinger,et al. Long-term exposure of human blood vessels to HIV gp120, morphine, and anandamide increases endothelial adhesion of monocytes: uncoupling of nitric oxide release. , 1998, Journal of cardiovascular pharmacology.
[9] T. Bilfinger,et al. Macrophage behavior associated with acute and chronic exposure to HIV GP120, morphine and anandamide: endothelial implications. , 1998, International journal of cardiology.
[10] T. Billiar,et al. Nitric oxide down-regulates hepatocyte-inducible nitric oxide synthase gene expression. , 1997, Archives of surgery.
[11] T. Dawson,et al. Neuronal (type I) nitric oxide synthase regulates nuclear factor kappaB activity and immunologic (type II) nitric oxide synthase expression. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[12] S. Murphy,et al. Nitric oxide regulates nitric oxide synthase-2 gene expression by inhibiting NF-kappaB binding to DNA. , 1997, The Biochemical journal.
[13] M. Goligorsky,et al. Cannabinoid Receptors Are Coupled to Nitric Oxide Release in Invertebrate Immunocytes, Microglia, and Human Monocytes* , 1996, The Journal of Biological Chemistry.
[14] G. Fricchione,et al. Morphine-induced conformational changes in human monocytes, granulocytes, and endothelial cells and in invertebrate immunocytes and microglia are mediated by nitric oxide. , 1996, Journal of immunology.
[15] T. Bilfinger,et al. Morphine stimulates nitric oxide release from invertebrate microglia , 1996, Brain Research.
[16] T. Bilfinger,et al. Effect of prolonged exposure to morphine on responsiveness of human and invertebrate immunocytes to stimulatory molecules , 1995, Journal of Neuroimmunology.
[17] T. Bilfinger,et al. Presence of the mu3 opiate receptor in endothelial cells. Coupling to nitric oxide production and vasodilation. , 1995, The Journal of biological chemistry.
[18] S. Mariotto,et al. Inhibition by sodium nitroprusside of the expression of inducible nitric oxide synthase in rat neutrophils , 1995, British journal of pharmacology.
[19] T. Bilfinger,et al. Human granulocytes contain an opiate alkaloid-selective receptor mediating inhibition of cytokine-induced activation and chemotaxis. , 1995, Journal of immunology.
[20] G. Stefano,et al. Microglia in invertebrate ganglia. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[21] S. Murphy,et al. Nitric oxide limits transcriptional induction of nitric oxide synthase in CNS glial cells. , 1994, Biochemical and biophysical research communications.
[22] T. Hughes,et al. Binding and pharmacological evidence for a special subtype of delta opioid receptor on human and invertebrate immune cells , 1992, Journal of Neuroimmunology.
[23] G. Stefano,et al. Stimulatory effects of opioid neuropeptides on locomotory activity and conformational changes in invertebrate and human immunocytes: evidence for a subtype of delta receptor. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[24] Xueji Zhang,et al. Nanometer size electrode for nitric oxide and S-nitrosothiols measurement , 2002 .
[25] M. Shichiri,et al. NO inhibits cytokine-induced iNOS expression and NF-kappaB activation by interfering with phosphorylation and degradation of IkappaB-alpha. , 1998, Arteriosclerosis, thrombosis, and vascular biology.
[26] S. Murphy,et al. Nitric oxide regulates nitric oxide synthase-2 gene expression by inhibiting NF- j B binding to DNA , 1997 .
[27] H. Magazine. Detection of endothelial cell-derived nitric oxide: current trends and future directions. , 1995, Advances in neuroimmunology.
[28] G. Stefano,et al. Evidence for the involvement of opioid neuropeptides in the adherence and migration of immunocompetent invertebrate hemocytes. , 1989, Proceedings of the National Academy of Sciences of the United States of America.